Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05781685 · ClinicalTrials.gov registry record · Early Phase 1
The Influence of Testosterone on Experimental Pain Perception
A Early Phase 1 study of Acute Pain, sponsored by University of New Mexi.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05781685 is a Early Phase 1 study of Acute Pain that has completed, run by University of New Mexi. The registered enrollment target is 20 participants, below the 268-participant average among 50 other Acute Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05781685, a Early Phase 1 study of Acute Pain, has completed, sponsored by University of New Mexi.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial examined how the administration of exogenous testosterone would influence pain tolerance and other endogenous steroids (i.e. estradiol and progesterone).
Conditions Studied
Interventions
- DRUG Testosterone
- OTHER Placebo Syrup
Study Locations (1)
New Mexico
- University of New Mexico - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2018-07-17 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05781685
The ClinicalTrials.gov registry entry for NCT05781685 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 268-participant average among 50 other Acute Pain trials with a reported enrollment target (93% lower). The listed sponsor is University of New Mexi, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Pain appearing as the primary indexed condition, and to 2 interventions - of which Testosterone is the first listed.
NCT05781685 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.
Frequently Asked Questions
What is clinical trial NCT05781685 about?
NCT05781685 is a clinical study titled "The Influence of Testosterone on Experimental Pain Perception". This trial examined how the administration of exogenous testosterone would influence pain tolerance and other endogenous steroids (i.e. estradiol and progesterone).
What is the current status of trial NCT05781685?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2017-10-01. Estimated completion is 2018-07-17.
What conditions does trial NCT05781685 study?
This clinical trial studies the following conditions: Acute Pain.
What interventions are being tested in trial NCT05781685?
The interventions under investigation include: Testosterone (DRUG), Placebo Syrup (OTHER).
Who is sponsoring clinical trial NCT05781685?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05781685 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Gabapentin vs. Placebo for Adjuvant Pain Control Following Acute Rib Fractures
COMPLETED · Early Phase 1
-
Characterization of Acute Pain
RECRUITING
-
Understanding the Acute Pain Phenotype in Patients Undergoing Surgery
RECRUITING
-
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
RECRUITING
-
Reducing Pain From Wisdom Molar Extractions
RECRUITING · Phase 2
-
Twin Block, Pain Medications and Third Molar Extractions
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.